Pharmacopeia and Irvine, California-based Allergan will collaborate in researching compounds for age-related macular degeneration. "We are working with Allergan to investigate alternate mechanistic approaches that could complement or potentially improve upon existing therapies," said Dr. David M. Floyd, chief scientific officer of Pharmacopeia. Release